{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:10:47Z","timestamp":1790611847383,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T00:00:00Z","timestamp":1655856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jconrel.2022.06.028","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T16:53:38Z","timestamp":1656176018000},"page":"771-785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV Pre-Exposure Prophylaxis"],"prefix":"10.1016","volume":"348","author":[{"given":"Fabiana","family":"Volpe-Zanutto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalitkumar K.","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismaiel A.","family":"Tekko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andi Dian","family":"Permana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akmal H.","family":"Sabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qonita K.","family":"Anjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen O.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro J.","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan F.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.06.028_bb0005","first-page":"1","article-title":"Predicting pharmacokinetics of a tenofovir alafenamide subcutaneous implant using PBPK modelling","author":"Rajoli","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0010","series-title":"Global HIV & AIDS Statistics","volume":"vol. 2","author":"UNAIDS","year":"2021"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0015","series-title":"HIV\/AIDS, 30 Novemb. 2021","author":"W. World Health Organization","year":"2021"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0020","author":"W. World Health Organization"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.addr.2021.04.002","article-title":"Microarray patches: breaking down the barriers to contraceptive care and HIV prevention for women across the globe","volume":"173","author":"Paredes","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(18)31311-4","article-title":"Seminar HIV","volume":"392","author":"Ghosn","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0035","doi-asserted-by":"crossref","first-page":"e402","DOI":"10.1016\/S2352-3018(17)30089-9","article-title":"Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study","volume":"4","author":"Molina","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11904-017-0353-0","article-title":"Long-acting Antiretrovirals: where are we now?","volume":"14","author":"Nyaku","year":"2017","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0045","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40262-017-0557-x","article-title":"In silico dose prediction for long-acting Rilpivirine and Cabotegravir administration to children and adolescents","volume":"57","author":"Rajoli","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/HIV.S97920","article-title":"Profile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to date","volume":"8","author":"Whitfield","year":"2016","journal-title":"HIV\/AIDS - Res. Palliat. Care."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/COH.0000000000000168","article-title":"Formulation and pharmacology of long-acting cabotegravir","volume":"10","author":"Trezza","year":"2015","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0060","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jac\/dkz504","article-title":"Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults","volume":"75","author":"Letendre","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.addr.2021.04.002","article-title":"Microarray patches: breaking down the barriers to contraceptive care and HIV prevention for women across the globe","volume":"173","author":"Paredes","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0070","first-page":"1","article-title":"Expert Review of Anti-infective Therapy Cabotegravir and rilpivirine for the treatment of HIV Cabotegravir and rilpivirine for the treatment of HIV","volume":"00","author":"Rial-crestelo","year":"2020","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/jan.13818","article-title":"The fear of needles: a systematic review and meta-analysis","volume":"75","author":"McLenon","year":"2019","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-019-4366-9","article-title":"Injection practices in 2011-2015: a review using data from the demographic and health surveys (DHS)","volume":"19","author":"Hayashi","year":"2019","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0085","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/ac2885","article-title":"Novel transdermal bioadhesive surfactant-based system for release and solubility improvement of antimalarial drugs artemether-lumefantrine","volume":"16","author":"Volpe-Zanutto","year":"2021","journal-title":"Biomed. Mater."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0090","article-title":"Systemic delivery of tenofovir alafenamide using dissolving and implantable microneedle patches","volume":"13","author":"Paredes","year":"2022","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0095","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4314\/ajtcam.v9i4.4","article-title":"Prevalence and Predictors of Traditional Medicine utilization among persons living with AIDS (PLWA) on Antiretroviral (ARV) and Prophylaxis treatment in both rural and urban areas South Africa","volume":"9","author":"Hughes","year":"2012","journal-title":"Afr. J. Tradit Complement Altern Med."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0100","first-page":"117","article-title":"Economic costs of malaria in children in three Sub-Saharancountries: Ghana, Tanzania and Kenya","volume":"16","author":"Sicuri","year":"2011","journal-title":"Tropical Med. Int. Health"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0105","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.xphs.2018.10.007","article-title":"Semisynthetic derivative of Artemisia annua-loaded transdermal bioadhesive for the treatment of uncomplicated malaria caused by plasmodium falciparum in children","volume":"108","author":"Zanutto","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jconrel.2021.03.036","article-title":"Artemether and lumefantrine dissolving microneedle patches with improved pharmacokinetic performance and antimalarial efficacy in mice infected with Plasmodium yoelii","volume":"333","author":"Volpe-Zanutto","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120885","article-title":"Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride","author":"Paredes","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0120","first-page":"1","article-title":"Microarray patches: poking a hole in the challenges faced when delivering poorly soluble drugs","volume":"2005792","author":"Paredes","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0125","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1002\/adfm.201200864","article-title":"Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery","volume":"22","author":"Donnelly","year":"2012","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejpb.2020.12.006","article-title":"Microneedle array systems for long-acting drug delivery","volume":"159","author":"Vora","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0135","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1021\/acs.molpharmaceut.0c00431","article-title":"Development, evaluation, and pharmacokinetic assessment of polymeric microarray patches for transdermal delivery of vancomycin hydrochloride","volume":"17","author":"Ramadon","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0140","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejpb.2020.12.003","article-title":"Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs","volume":"158","author":"Anjani","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0145","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.xphs.2016.01.019","article-title":"Self-assembly of Cyclodextrins and their complexes in aqueous solutions","volume":"105","author":"Ryzhakov","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0150","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1007\/s11095-007-9506-y","article-title":"Structural behaviour of 2-hydroxypropyl-\u03b2-cyclodextrin in water: molecular dynamics simulation studies","volume":"25","author":"Yong","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111547","article-title":"Hydrogel-forming microneedles prepared from \u201csuper swelling\u201d polymers combined with lyophilised wafers for transdermal drug delivery","volume":"9","author":"Donnelly","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0160","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s11095-020-02887-9","article-title":"Two-photon polymerisation 3D printing of microneedle Array templates with versatile designs: application in the development of polymeric drug delivery systems","volume":"37","author":"Cordeiro","year":"2020","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0165","series-title":"Adv. Anal. Chem. Instrum.","first-page":"117","article-title":"Phase-solubility techniques","author":"Higuchi","year":"1965"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0170","first-page":"2106999","article-title":"Novel bilayer microarray patch-assisted long-acting Micro-depot Cabotegravir intradermal delivery for HIV pre-exposure prophylaxis","author":"Tekko","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0175","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpharm.2011.03.051","article-title":"Higuchi equation: derivation, applications, use and misuse","volume":"418","author":"Siepmann","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejpb.2020.06.025","article-title":"Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis","volume":"154","author":"Permana","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120885","article-title":"Novel tip-loaded dissolving and implantable microneedle array patches for sustained release of finasteride","volume":"606","author":"Paredes","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0190","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jconrel.2010.08.008","article-title":"Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution","volume":"147","author":"Donnelly","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114698","article-title":"HPLC-MS method for simultaneous quantification of the antiretroviral agents rilpivirine and cabotegravir in rat plasma and tissues","volume":"213","author":"Ram\u00f6ller","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0200","doi-asserted-by":"crossref","first-page":"38745","DOI":"10.1021\/acsami.1c11179","article-title":"Albendazole nanocrystal-based dissolving microneedles with improved pharmacokinetic performance for enhanced treatment of cystic echinococcosis","volume":"13","author":"Permana","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2016.06.023","article-title":"Evaluation of geometrical effects of microneedles on skin penetration by CT scan and finite element analysis","volume":"107","author":"Loizidou","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0210","series-title":"Goodman Gilman\u2019s Farmacol. Basis Ther., 12a ed","article-title":"Dermatological Pharmacology","author":"Burkhart","year":"2012"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0215","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jconrel.2018.07.009","article-title":"Hydrogel-forming microneedles enhance transdermal delivery of metformin hydrochloride","volume":"285","author":"Migdadi","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0220","series-title":"Verena; Thaler, Crystalline Forms of Cabotegravir Sodium, WO 2018149608 (A1)","author":"Adamer","year":"2018"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0225","first-page":"1","article-title":"Solubility enhancement of myricetin by inclusion complexation with heptakis-o-(2-hydroxypropyl)-\u03b2-cyclodextrin: a joint experimental and theoretical study","volume":"21","author":"Han","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0230","article-title":"NMR studies of Cyclodextrins and Cyclodextrin complexes","volume":"2665","author":"Schneider","year":"1998","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0235","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mrc.1260250306","article-title":"Cyclodextrins as chiral complexing agents in water, and their application to optical purity measurements","volume":"25","author":"Greatbanks","year":"1987","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0240","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2019.05.037","article-title":"2-Hydroxypropyl-\u03b2-cyclodextrin-enhanced pharmacokinetics of cabotegravir from a nanofluidic implant for HIV pre-exposure prophylaxis","volume":"306","author":"Pons-Faudoa","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0245","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s13346-020-00727-2","article-title":"Evaluation of the clinical impact of repeat application of hydrogel-forming microneedle array patches","volume":"10","author":"Al-Kasasbeh","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0250","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2018.11.002","article-title":"Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension","volume":"292","author":"Mc Crudden","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.06.028_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2021.04.024","article-title":"Etravirine-loaded dissolving microneedle arrays for long-acting delivery","author":"Rojekar","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0260","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/15284336.2018.1511346","article-title":"Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: patient perspectives from the ECLAIR trial","volume":"19","author":"Murray","year":"2018","journal-title":"HIV Clin. Trials."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0265","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1909512","article-title":"Long-acting Cabotegravir and Rilpivirine after Oral induction for HIV-1 infection","volume":"382","author":"Orkin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2022.06.028_bb0270","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.vaccine.2014.01.076","article-title":"Microneedle patches: usability and acceptability for self-vaccination against influenza","volume":"32","author":"Norman","year":"2014","journal-title":"Vaccine."},{"key":"10.1016\/j.jconrel.2022.06.028_bib271","doi-asserted-by":"crossref","first-page":"121835","DOI":"10.1016\/j.ijpharm.2022.121835","article-title":"Super-swelling hydrogel-forming microneedle based transdermal drug delivery: Mathematical modelling, simulation and experimental validation","volume":"622","author":"Ranjan Yadav","year":"2022","journal-title":"Int. J. Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.06.028_bib272","doi-asserted-by":"crossref","first-page":"S996","DOI":"10.1093\/ofid\/ofz415.2491","article-title":"LB8. Microarray Patch Delivery of Long-Acting HIV PrEP and Contraception","volume":"6","author":"Rein-Weston","year":"2019","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1016\/j.jconrel.2022.06.028_bib273","first-page":"112226","article-title":"Hydrogel-forming microneedles for rapid and efficient skin deposition of controlled release tip-implants","volume":"127","author":"Peng","year":"2021","journal-title":"Materials Sci. Eng.: C"},{"key":"10.1016\/j.jconrel.2022.06.028_bib274","series-title":"Long-Acting Drug Delivery Systems","first-page":"249","article-title":"9 - Long-lasting drug delivery systems based on microneedles","author":"Vora","year":"2022"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922003662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922003662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:37:28Z","timestamp":1759163848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922003662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":58,"alternative-id":["S0168365922003662"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.06.028","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrogel-forming microarray patches with cyclodextrin drug reservoirs for long-acting delivery of poorly soluble cabotegravir sodium for HIV Pre-Exposure Prophylaxis","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.06.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}